| Financial Year |
March 31 2023 |
| Monetary Funds |
1,397,105,006.67 |
| Held-for-trading Financial Assets |
150,279,287.67 |
| Notes Receivable |
248,480,997.85 |
| Accounts Receivable |
402,468,009.21 |
| Advances to Suppliers |
62,394,374.40 |
| Other Receivables |
115,239,579.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
620,202,793.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
166,716,292.00 |
| Total Current Assets |
3,429,983,040.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
121,159,570.21 |
| Investment Properties |
-- |
| Fixed Assetes |
547,904,066.73 |
| Under-construction Projects |
11,250,358.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
192,980,419.77 |
| R&D expenses |
27,749,696.99 |
| Goodwill |
14,073,873.04 |
| Long-Term Deferred and Prepaid Expenses |
41,356,715.70 |
| Deferred Income Tax Assets |
9,078,723.27 |
| Other Non-Current Assets |
16,529,535.18 |
| Sub-Total of Non-Current Assets |
1,102,304,458.65 |
| Total Assets |
4,532,287,499.46 |
| Short-Term Loans |
51,539,744.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
384,623,578.56 |
| Accounts Payable |
379,080,960.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
47,882,993.54 |
| Taxes Payable |
60,271,841.86 |
| Interest Payable |
-- |
| Dividend Payable |
1,002,857.40 |
| Other payables |
460,387,086.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,762,077.11 |
| Other Current Liabilities |
62,568,157.43 |
| Sub-Total of Current Liabilities |
1,556,529,253.30 |
| Long-term Loans |
12,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,193,868.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,648,495.45 |
| Other Non-Current Liabilities |
1,900,000.00 |
| Sub-Total of Non-Current Liabilities |
98,930,438.54 |
| Total Liabilities |
1,655,459,691.84 |
| Paid-In Capital(Or Share Stock) |
429,887,117.00 |
| Capital Surplus |
639,601,706.10 |
| Surplus Reserve |
220,547,059.60 |
| LESS:Treasury Stock |
42,249,200.00 |
| Undistributed Profits |
1,014,731,121.30 |
| Minority Stockholder's Interest |
612,905,961.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,263,921,846.62 |
| Owner's Equity（Stockholder's Equity） |
2,876,827,807.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,532,287,499.46 |
